HomeINMB • NASDAQ
add
INmune Bio Inc
Previous close
$5.00
Day range
$5.01 - $5.12
Year range
$4.78 - $14.74
Market cap
113.30M USD
Avg Volume
294.05K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 9.86M | 52.78% |
Net income | -9.75M | -49.92% |
Net profit margin | — | — |
Earnings per share | -0.50 | -38.89% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 31.07M | -35.04% |
Total assets | 52.45M | -24.77% |
Total liabilities | 15.37M | -19.37% |
Total equity | 37.08M | — |
Shares outstanding | 19.78M | — |
Price to book | 2.72 | — |
Return on assets | -49.68% | — |
Return on capital | -62.06% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -9.75M | -49.92% |
Cash from operations | -7.89M | -148.46% |
Cash from investing | — | — |
Cash from financing | 13.00M | — |
Net change in cash | 5.07M | 259.44% |
Free cash flow | -4.48M | -304.23% |
About
Founded
2015
Headquarters
Website
Employees
14